[
  {
    "request": {
      "base_url": "https://openrouter.ai/api/v1",
      "model": "openai/gpt-5-mini",
      "messages": [
        {
          "role": "user",
          "content": "A 65-year-old man presents with progressive, short-distance, intermittent claudication in his right leg and a declining ABI. He undergoes an abdominal aortic angiogram with runoff demonstrating a discrete 90% stenotic lesion of the superficial femoral artery. Percutaneous transluminal angioplasty followed by placement of a self-expanding nitinol mesh stent is performed with good post-procedural angiographic results.\n\nWhich of the following is the most appropriate post-procedure surveillance program for this patient?\n\n A. \n B.\t\n C. \n D.\t\n E. \n\nAnswer Choices:\nA. Regular visits with assessment for interval change in symptoms, vascular examination, and ABI measurement beginning in the immediate postprocedure period and at intervals for at least 2 years\nB.  Regular visits with assessment for interval change in symptoms, vascular examination, and arterial duplex at 1 month, 3 months, and at month 12\nC. Regular visits with assessment for interval change in symptoms, vascular examination, and ABI measurement at 3 months, 6 months, 9 months, and at month 12\t\nD.  Regular visits with assessment for interval change in symptoms, vascular examination, and arterial duplex at 3 months, 6 months, 12 months, and 2 years\nE. Annual visits with assessment for interval change in symptoms, vascular examination, ABI measurement, and arterial duplex"
        }
      ],
      "reasoning_effort": "medium",
      "response_format": {
        "type": "json_schema",
        "json_schema": {
          "name": "answer",
          "strict": true,
          "schema": {
            "type": "object",
            "properties": {
              "answer": {
                "type": "string"
              },
              "answer_letter": {
                "type": "string",
                "enum": [
                  "A",
                  "B",
                  "C",
                  "D",
                  "E"
                ]
              }
            },
            "required": [
              "answer",
              "answer_letter"
            ],
            "additionalProperties": false
          }
        }
      },
      "usage": {
        "include": true
      }
    },
    "response": {
      "id": "gen-1762203103-fZuDwP4Ck5dELkuaIY3O",
      "choices": [
        {
          "finish_reason": "stop",
          "index": 0,
          "logprobs": null,
          "message": {
            "content": "{\"answer\":\"D\\n\\nRegular post-stent surveillance should include clinical assessment and arterial duplex imaging to detect restenosis early. For femoropopliteal (SFA) stents the usual program is duplex at about 3 months, 6 months, 12 months and then yearly (eg, 2 years shown here) with interval symptom/vascular exam \u2014 option D best matches recommended practice.\",\"answer_letter\":\"D\"}",
            "refusal": null,
            "role": "assistant",
            "annotations": null,
            "audio": null,
            "function_call": null,
            "tool_calls": null,
            "reasoning": "**Analyzing follow-up options**\n\nI'm looking at different options for follow-up visits after a procedure. I see options ranging from regular assessments with ABI checks to more structured visits with duplex ultrasound. Options B, D, and E include arterial duplex surveillance, which could be important for detecting restenosis early. The frequency I'd suggest seems to lean towards visits at 3 months, 6 months, and 12 months, with perhaps an additional visit after 1 month to ensure thorough monitoring.**Recalling guidelines for surveillance**\n\nI\u2019m thinking back to the American Heart Association's 2016 update. It suggests conducting clinical assessments and noninvasive tests like ABI and duplex at 1 month, 6 months, and then every 6-12 months after procedures. For femoropopliteal stents, it seems duplex should happen at 3, 6, and 12 months. Option D, which includes duplex at 3, 6, 12 months, and 2 years seems most robust, though it\u2019s missing the 1 month, which may be less common in practice.**Selecting the best surveillance option**\n\nI\u2019m evaluating exam answers regarding follow-up after femoropopliteal angioplasty with a stent. It seems that D is the best option since it recommends duplex ultrasound at 3, 6, and 12 months, plus yearly checks thereafter. Option A only includes ABI, which isn't as sensitive for detecting restenosis, while Option C has frequent ABI checks that are still less sensitive. Option B misses the 6-month assessment, and Option E's annual check is too infrequent. I'll go with D and justify it based on the importance of detecting restenosis with duplex surveillance.",
            "reasoning_details": [
              {
                "type": "reasoning.summary",
                "summary": "**Analyzing follow-up options**\n\nI'm looking at different options for follow-up visits after a procedure. I see options ranging from regular assessments with ABI checks to more structured visits with duplex ultrasound. Options B, D, and E include arterial duplex surveillance, which could be important for detecting restenosis early. The frequency I'd suggest seems to lean towards visits at 3 months, 6 months, and 12 months, with perhaps an additional visit after 1 month to ensure thorough monitoring.**Recalling guidelines for surveillance**\n\nI\u2019m thinking back to the American Heart Association's 2016 update. It suggests conducting clinical assessments and noninvasive tests like ABI and duplex at 1 month, 6 months, and then every 6-12 months after procedures. For femoropopliteal stents, it seems duplex should happen at 3, 6, and 12 months. Option D, which includes duplex at 3, 6, 12 months, and 2 years seems most robust, though it\u2019s missing the 1 month, which may be less common in practice.**Selecting the best surveillance option**\n\nI\u2019m evaluating exam answers regarding follow-up after femoropopliteal angioplasty with a stent. It seems that D is the best option since it recommends duplex ultrasound at 3, 6, and 12 months, plus yearly checks thereafter. Option A only includes ABI, which isn't as sensitive for detecting restenosis, while Option C has frequent ABI checks that are still less sensitive. Option B misses the 6-month assessment, and Option E's annual check is too infrequent. I'll go with D and justify it based on the importance of detecting restenosis with duplex surveillance.",
                "format": "openai-responses-v1",
                "index": 0
              },
              {
                "type": "reasoning.encrypted",
                "data": "gAAAAABpCRXvVh62QRNJ4loBlg_KX41lbpuY2hqVbJp8eQFgK0mdSZF-iYygj9KpMw-OJ6CnFO8Yqhh9GfMQf5qiIC9BwmZtXMN_xgzfvXU3qnBjR8JYZC2JNDQcj_Sizm93oD0OLzTUjFKI2fPUASXxPOdnr87IMtEjrZbn2cwavakw545qx6dSV94AG6ySxZHl0aVh9JkiQlMpi63z1rL8r05kVLlRWaZsQLPoHI_6GBx2nbWS-ZMxN8pfTk_al927OgcHz1Fr8CmSvyQbZrwGh2lmjlpptXVb4jP70sUmUVaOHBqHu0D1qhZx4wCPJBBo7pkUlezAND5CvzEQ16CPs1veHu7N66Ku4qFyD1BzjVBoIUu1NdRIDRWClgQ7rpgIc2jR2n4qsJ3l2-fNt57M2v1Sb6B8bXWtXT9xe4sFh16zpmb2wyTj4Pp_D27SrlcafJaOoQhySj2ycKhFEs97h-SCaS-mSvSIn8fZzpkq9eTwiNpry1HYShnPL-64q7n-DLbLwCXEp8OoxG4rfHUXmrcvvsJFMZsw7aFz55M2RRnoADe27rol9AKygMKEOCXD7u5F71kBk_YWTze-LhSi6YURW4y9BTwkKrwRR89KDITU42D047qRZZllISdaINcQE3WoTIifGUdZvAgkWDHlBmGzfz_7XLHTWJsatQ-dJ9MX-z63ztDHb7lfWTkPu-lQL7JUuVJTr1Zvdlwg0YpAR7iKeVKpaXsQAZox8N585XqZVu_AjN7e2YRkWJDScDYiD9S8jM6C4TQW9N1lTktW-l8kCoHyR4kZzH_n93oX_EIAHb7tW5R3_NXpPrvtMMgPfB2t3Qz0JsZz64c5gNcqw23IlDFTF603Hv01WMPMvuDLBi7bb2MnIiPHwPIJWc--OpJB0-ecd2J3w3PriXweBQpPN2OSEiCzDtS_a1eFCz9AhiRNsq5CdDPuGj3nT2EqZI3M2KZVH_4XuvCONuO-qrROdi3RoW8hnZLZBxpscAaXSYnLQRA3wZRvRyHXeyd6SKnwEAAKRs4gP5BrQYl58uTyrdcnMkyrd1QkUVyO45A7h07o3MulQWtJQtuleNwI3FN7H7NxZFESzOVBKN5KrPETwkCA2RaWUvIURjZW3APyykBYetran1pRBCLECrXjvQog2vohUOk56RFQ7GzNL0s_eWBX4390KLnf-Uue3ppk-dvI9YAVx1S6zl2JFp1aTy7okCO2mk11P0IuRqFMrdadkM7QrnJw8nA_P3bKJ5pO0xLt0h_abTkabfYeIZy9Mlk47DFXVnpRX5eAInHaspJ-udOvmkjmlDUACB1UrgOVp_QEJJ0A1aXxpwu8Vu-CKiG_sWtD8MWcHxPOuAQbSBkQhcJx6wupk2j2xxCASH8LaESTPDQb9Viv2kQdd3EfT_ZTJW5YnJDtn2ealO4eOpOTJ83xWZrOzeHSSzBXu-gCwQWCr7C63zPHR5nwcKz1vbfopKmComLDEzQqaQMMO6qQUtgQN_HjVqPf-7a7rPXSFJ1pYiNoA7HzvaoGHc_UybKOOKKgDKK1v9B2q2WZ8TAWIoGIx-oYTsA5Q4Vf9soD6tn7QwjZwTSWepH2BFa_Cj-pmlRr6jJPsr5odE0LU3KPZ7wNpEp0sGjROCQBjBZxTKN04dMbsAUrwTl462zCKgitvJq5ftmgIm3tgzoa8TiPwwyRMo2-vBiajy3eqp12v_N8odHUrxM2GaQUwY_FXkIa8yIys6tU9PYRxe-RxP3I_U1V57GuSKSt0ilGLMfYklJTPTp_i33a4OjZaJxZ557frqkHOYMu23GvMSBAh2mqmjXUVarKKa9jIsP2GXHaDy8qtNIXEnyNfgnZE46uJbvdewMl0SGexkVHZwuF9fFw1KYXD_6g6kFVHcz3HqKQtR5T38ISe1BYrada7Ox92paiFunqIZazFWLqEw87VN1sYzEHVbOG6VJu2koguoBJW1OW3JutmxB2AZuqk2tN7EFWA31cpMoO0ymlWQpPj0Z59Kh_pWb3i4sZsSnjIw-6IhRiO_hFm2Rd7hglElkR_6Ugz8C0RNJMyz2wj3dOvTLr87CKy-B9GgG66yQJ9fu5sUqbOSzMTKV_Dw-6IxSZmPqZ7K09WXIhgKj-bi3t-Ph1bTEfTjQXufpU1Z2dB-dTJruF-Zu5paafAbUAh30rQHNDlIjqBcRi92zhsnypHb9J-GYeGH5meG3xhUBX-PRC7-pwnzqiStyz4IMvzh0ijp3fpl5RQuTYw6NgwMNnQ4TqEYGKZjSQ_a2gTJdv4Cs7n1i8IvxPn2Xnk-pfLvkcdGD-2VWAvshyI-7hAd-x_uvZYPU81KtAz46C3UcVzKk1EaIgf0KrJyPUnb-xQ453F6pv3MjX-VhT7ybZF8W2rfsTRd4vbPPWP3KBtXn1k_rxymnAgqBnMe9Blri4DS35WHHIzi9x6b-BLhLujxVWlcwiZe6tgImlMyJoJaFeFG1xHzqqjy42B6UbLlcvcft_C1Oa_i6JvMb7mNoOKXoPeKq9w-LCHK5vs4wdgEq6mfLt-SvrHnCfeoAY_feZSy3TrChSpr2oXvdBtU3HY9LwOcdauAQ0Zt4f-kgkJAavOQ06fLVlr-OB7aIN14aHleQlpAcoVvsQIeq5ALPAnGExrJRhJGSSYw_AaMKjMd_rHeIrsm_Btcg7Mjp9x20rpnwfJ4_I4EAOHgzoLNUaoi-38wfpeAcCUAFAlpJ4MjqpHo-_ZsoNd4ifUYmBZwF8-YD4EjSbJxuGb7r5tvu-YFrJJwMLqDyVCLFNcMW1ucfzOE22INaxsvu-6s_nytd_jMecqMKpEl4giAT_i3DlqSS64ESLaFcFA2bFOMzn9bBRcSTP9SzXyjXpDMuhUEtjWsfvsbzMKfacoYj_nBukswR0zXmq1xKeQA_d6RFjN8cML_JMxzKcthdkCyFKVknBmtOBRZ_Y53VLd6oeCzbHaaRVtQ8xadxxNocXi8UtR9ajJQIGblzu4JHmHEqWrYtggvZWiMHbP3GnLeTgwlYVyBKKawkMAcUzz2OCOxMO0qOWuvq_ppFhkTzT68IP_KJetZgD8neRT1J7EfNf0ze3KWbTUupgkZKQIjqGxrbTFoTe_s3inXpRoDR5ymXMz67ZmwNoX6bewcRTYdLGe0SvkMgiQnRNEdA6GiaNgea6XQao13xe4s_L4MBkB4IVR5jmXQY6jLFvbwWXEh-9lhsPvTST35j0LrBsqdkDo6UUPETiRDhorrzbH5Tw4G0bWlpD9HECabZC-Njt3OCK97ZvmdR5lNJthz9k8Ckk41NmwTP0SWcFuaYrNxlov41HfhKAOq67mUtduXAzFAXAo2S99Pn4ej0K8Pb53yT0H4077mIB9oRN2by_ld4xE8ob2UgBuRphngJW8rtLgry3akAhFR67v4MrDzpqU1cCacx5go1NsEDioYI6s58nIfYxJe9F5lRKgYBhr3Dp2z0z-6Z0Lizv_ihOz99NjctnWqZPTJMQxb_mz9LkZPY63SlY4B53x5tV3ZHf7BM0Z-3nOoq8buDC5GwUZzlUUeuJEAKWJu_aFpuWR_4_mpDCwcvAp82M9H3P3c_TrQ0ETLA09zkYdmlW2JF8l2yPqkqgTKQjFenBq43P-76UIektNmBCr23_lbeCj927AJlDK_NFCPR7UxmSQ-33rCoHZjwQ_QMKrfXeHK-M75gsrVpUzh00nu24bgB2XbviUbVmWBNP3OGCzHn6pJR9v5r3GltM0Wkub1_Ud17RI2En079zMsC5oyMUml7SE44NtOsTpPuA1cjAzuqVWomGlqim1WQVVs0ktGZF4qLM7vMaM4m1SBRh6xTrOt-_UJu9n1f5wb1mnvc2qCVSm8Wr_m3Ts0iaDbnyE23Lvq9_UnshZoFMIuoFvTukO8EQc5gbqeHLQwSwZrDEaWfxKwXjiEShC--qDTxirPnd-z97DPS7H266eU85joXBlZ6PAmChY7LHcxKNxNHuCKEfBP9rBvPvrvAhSsHJLaofVI1hIt6qOfmu7SRZAcdM6tv4-zHfyef8ibPsdQJE63zUOVNX6S9-VK_RBWdXsFbfLgoMIFuM5_1uBQTV0u8VY4bdnwwcgVxEAkT3pOEFPrpzcf9SdBDOaRUF6Sho2YPPg8WwWCu5jF5EYKDIqYaZCG6A0iNUC83Z8bjT9MKYFsIAK5lxfBOanDq4fGXYbi2aFgLCuciolpnKS6Tdgh_2F1HXRi2eTNQ1nKyPOKykZ6N_M09aJVYYYneALm-85nojwBk-jPig-WtYKY_3xalZL07UEbSUr1GXZe9F65P542KYsVqOmsoraJ-_X1PIGpnLmkdrgVv_3HRNaKFtZcf2nVNWOLEN7WbaBV0DNyZMCwV0gCLDoU05SgqnIyq0HrG7ikA34tQgOcTap09UATKdk0N33OyZ-Qm3E_L0msu8ClS3wXfOAo23NpRVn5MP6ZPTRdgoDAD9qFdjpiAxOkRv7NFIwiH_Y8qSL3wRq9KUF2LrnmnBQ8c8508V39zBR5Cj_VyfaWsW7m-4Cn4NE4IxavFcmKYSGqUPWKEDmkHZB03c9j_3iAL3wD-TnSxRg8xMMuN3xyNBQ7Eih_AOixII_oNSruB--436CU4f_LNW3IdejihxXXaMGf13aDrNz7iaqMKR5XZYeh0m1-3eR3CuGC7WcH6bgoO7Y8wBZXt3UG9CO4Q-zQL_SPCp8ygqPkXomDHokqw7doYiN3D0VdSVyi_gthprJcPUuzlzPEigTQ4A0fhl4md1ewaQrARxYzGH-z-EfRnkEocsuWxta1ssBzIo93l0X4D1616xVhz1X4r33Wjgju9VzW8rIqG5ppVzFg_7_qU0JYXBUMt7sYyIBCxJ75Uc8h5SVFtpPduaO-wrXtWJN0iPOf3cO8Opr-I_bnZu-UheHobUKUEmUKJQAy3lbFAxgMjeosoMxJFUr1lpoHdnzhP6v1UISpC_e7MYOFS8dLo5e3e-VW2LuM52bYl8NUZ46qUSZfVezK8x_mV6S58JWWTNX2SMKmKtHZK9D9m8zr6cmaZjR4gLaqMiCVbo1xOn2juXnKwo4BfIqyMYwmu16n29JPevw6mp0kdCD-VfoRL5Q1xvZKPE3RZl3gk92Bzb0tTaH5zaIYHkgmFeCGdKjvQ2yJUJT_ZH7WCxnaT8WQEp7jiE7hQ7Tg9rPz_czy0DS8xz5VVyafNqXcBWxEvwy9K-6S3n44rhtUiuDDgJ4G-RsQ3VOYZhVP6t-yqzxyKHKtcgwOkDjj3WU4f3QMWmVOhDcjrSFfqys_rmi4FM2Wb0NPuWushOG1sdknxiKID3DjumRJehO_qDGQTSX4-iffYJyKvbYE5uXTvk3nTo0qCItlSg-BNy44KUGI9XO65opwAQmFgmZIgVym653Y0OWVmHiukodGIX4dYEMgYziIl2MGU=",
                "id": "rs_07c1de89fc6c0d8b01690915e0773c8190b3ec7a1e7388fce8",
                "format": "openai-responses-v1",
                "index": 0
              }
            ]
          },
          "native_finish_reason": "completed"
        }
      ],
      "created": 1762203103,
      "model": "openai/gpt-5-mini",
      "object": "chat.completion",
      "service_tier": null,
      "system_fingerprint": null,
      "usage": {
        "completion_tokens": 864,
        "prompt_tokens": 333,
        "total_tokens": 1197,
        "completion_tokens_details": {
          "accepted_prediction_tokens": null,
          "audio_tokens": null,
          "reasoning_tokens": 768,
          "rejected_prediction_tokens": null,
          "image_tokens": 0
        },
        "prompt_tokens_details": {
          "audio_tokens": 0,
          "cached_tokens": 0
        },
        "cost": 0.00181125,
        "is_byok": false,
        "cost_details": {
          "upstream_inference_cost": null,
          "upstream_inference_prompt_cost": 8.325e-05,
          "upstream_inference_completions_cost": 0.001728
        }
      },
      "provider": "OpenAI"
    }
  },
  {
    "request": {
      "base_url": "https://openrouter.ai/api/v1",
      "model": "openai/gpt-5-mini",
      "messages": [
        {
          "role": "user",
          "content": "A 65-year-old man presents with progressive, short-distance, intermittent claudication in his right leg and a declining ABI. He undergoes an abdominal aortic angiogram with runoff demonstrating a discrete 90% stenotic lesion of the superficial femoral artery. Percutaneous transluminal angioplasty followed by placement of a self-expanding nitinol mesh stent is performed with good post-procedural angiographic results.\n\nWhich of the following is the most appropriate post-procedure surveillance program for this patient?\n\n A. \n B.\t\n C. \n D.\t\n E. \n\nAnswer Choices:\nA. Regular visits with assessment for interval change in symptoms, vascular examination, and ABI measurement beginning in the immediate postprocedure period and at intervals for at least 2 years\nB.  Regular visits with assessment for interval change in symptoms, vascular examination, and arterial duplex at 1 month, 3 months, and at month 12\nC. Regular visits with assessment for interval change in symptoms, vascular examination, and ABI measurement at 3 months, 6 months, 9 months, and at month 12\t\nD.  Regular visits with assessment for interval change in symptoms, vascular examination, and arterial duplex at 3 months, 6 months, 12 months, and 2 years\nE. Annual visits with assessment for interval change in symptoms, vascular examination, ABI measurement, and arterial duplex"
        }
      ],
      "reasoning_effort": "medium",
      "response_format": {
        "type": "json_schema",
        "json_schema": {
          "name": "answer",
          "strict": true,
          "schema": {
            "type": "object",
            "properties": {
              "answer": {
                "type": "string"
              },
              "answer_letter": {
                "type": "string",
                "enum": [
                  "A",
                  "B",
                  "C",
                  "D",
                  "E"
                ]
              }
            },
            "required": [
              "answer",
              "answer_letter"
            ],
            "additionalProperties": false
          }
        }
      },
      "usage": {
        "include": true
      }
    },
    "response": {
      "id": "gen-1762203103-YusgbANlP4uDU15oLBoW",
      "choices": [
        {
          "finish_reason": "stop",
          "index": 0,
          "logprobs": null,
          "message": {
            "content": "{\"answer\":\"D\\n\\nRationale: After femoropopliteal (SFA) stenting the preferred surveillance is serial clinical assessment with arterial duplex surveillance to detect in\u2011stent restenosis early (most events occur in the first year). Duplex exams at 3, 6, 12 months and at 2 years (with interval clinical/ABI checks as indicated) are the most appropriate choice here. ABI alone or annual-only follow up is less sensitive for early in\u2011stent restenosis.\",\"answer_letter\":\"D\"}",
            "refusal": null,
            "role": "assistant",
            "annotations": null,
            "audio": null,
            "function_call": null,
            "tool_calls": null,
            "reasoning": "**Considering surveillance guidelines**\n\nI need to recall the surveillance protocol after SFA stent placement, specifically for self-expanding nitinol stents. For peripheral arterial interventions, follow-ups typically include clinical assessments and non-invasive imaging like ABI and duplex ultrasound. The literature suggests duplex surveillance at 1, 3, 6, 12 months, and then annually for better detection of restenosis, especially since bare-metal nitinol stents have higher rates of restenosis within the first year. Many centers adhere to this schedule.**Evaluating follow-up protocols**\n\nI need to assess the most appropriate follow-up protocol after stent placement. Some options suggest regular visits with assessments and ABI measurements for at least two years, while others emphasize annual visits with ABI and duplex, which seems infrequent. Many standards advocate for duplex surveillance at 1 month and 3 months to establish a baseline, then at 6 months. The Society for Vascular Surgery recommends duplex at 1, 3, 6, and 12 months for specific procedures, so I should stick to those guidelines.**Assessing surveillance options**\n\nAfter placing an SFA stent, in-stent restenosis usually shows up within the first 6-12 months. The surveillance program needs early baseline duplex at 1 month, then at 3, 6, 12 months, and annually. However, no options cover all these checkpoints. Option B includes 1, 3, and 12 months, while option D covers 3, 6, 12, and 2 years. I think D is better since it has duplex at 3 months, but it misses the 1-month baseline. Both A and C rely solely on ABI, which is why I lean towards D.**Choosing the right surveillance schedule**\n\nAfter peripheral arterial interventions with a stent, duplex ultrasound is recommended at 1 month, 6 months, and then annually. The options are a bit limited: Option B has 1, 3, and 12 months, while D includes 3, 6, 12 months, and 2 years. I think I'll go with D because it covers crucial time frames and includes arterial duplex studies. It's also implied that regular visits post-procedure will assess symptoms and vascular health. I'll explain my reasoning for picking D over the others, emphasizing the need for early monitoring to catch in-stent restenosis before it becomes an issue.**Finalizing surveillance choice**\n\nI need to remember that an ABI alone isn't sufficient for monitoring after stent placement. While a 1-month duplex is optional, it's best to schedule serial duplex ultrasounds at 3, 6, and 12 months. This approach allows for early detection of any issues and is more thorough than relying on ABI alone. Therefore, I'll choose answer D and explain that my rationale focuses on the importance of frequent duplex assessments for effective surveillance.",
            "reasoning_details": [
              {
                "type": "reasoning.summary",
                "summary": "**Considering surveillance guidelines**\n\nI need to recall the surveillance protocol after SFA stent placement, specifically for self-expanding nitinol stents. For peripheral arterial interventions, follow-ups typically include clinical assessments and non-invasive imaging like ABI and duplex ultrasound. The literature suggests duplex surveillance at 1, 3, 6, 12 months, and then annually for better detection of restenosis, especially since bare-metal nitinol stents have higher rates of restenosis within the first year. Many centers adhere to this schedule.**Evaluating follow-up protocols**\n\nI need to assess the most appropriate follow-up protocol after stent placement. Some options suggest regular visits with assessments and ABI measurements for at least two years, while others emphasize annual visits with ABI and duplex, which seems infrequent. Many standards advocate for duplex surveillance at 1 month and 3 months to establish a baseline, then at 6 months. The Society for Vascular Surgery recommends duplex at 1, 3, 6, and 12 months for specific procedures, so I should stick to those guidelines.**Assessing surveillance options**\n\nAfter placing an SFA stent, in-stent restenosis usually shows up within the first 6-12 months. The surveillance program needs early baseline duplex at 1 month, then at 3, 6, 12 months, and annually. However, no options cover all these checkpoints. Option B includes 1, 3, and 12 months, while option D covers 3, 6, 12, and 2 years. I think D is better since it has duplex at 3 months, but it misses the 1-month baseline. Both A and C rely solely on ABI, which is why I lean towards D.**Choosing the right surveillance schedule**\n\nAfter peripheral arterial interventions with a stent, duplex ultrasound is recommended at 1 month, 6 months, and then annually. The options are a bit limited: Option B has 1, 3, and 12 months, while D includes 3, 6, 12 months, and 2 years. I think I'll go with D because it covers crucial time frames and includes arterial duplex studies. It's also implied that regular visits post-procedure will assess symptoms and vascular health. I'll explain my reasoning for picking D over the others, emphasizing the need for early monitoring to catch in-stent restenosis before it becomes an issue.**Finalizing surveillance choice**\n\nI need to remember that an ABI alone isn't sufficient for monitoring after stent placement. While a 1-month duplex is optional, it's best to schedule serial duplex ultrasounds at 3, 6, and 12 months. This approach allows for early detection of any issues and is more thorough than relying on ABI alone. Therefore, I'll choose answer D and explain that my rationale focuses on the importance of frequent duplex assessments for effective surveillance.",
                "format": "openai-responses-v1",
                "index": 0
              },
              {
                "type": "reasoning.encrypted",
                "data": "gAAAAABpCRXyitTEZwqzBF4h8P2sIyJnSeSZ0IPINyjM3BSJ61FI850jLRVAOeKg9q3EzrcI4mNm46uMcBbGhKPLJImg7IvCbiVimLO4NBG7Nl-t2BFVEVhWj40-fXwHlC2ZCz1nUbB0lCbu49dan7lao2ohfzDYYuMwOaeEXlzwhPgYQTGOHYmPTvtdgHwCJ0kSFU_ytuzzUlKsYRQaibhCV5OqPF770HlI-iQjUKU1bKWhBjRP0hOHY_LPQOeNob2pPaHGhsLE7Lpalazqz6k4lxUKaf-kt8GYewIsihDpuJknIgUUwL8FIawuFginbGdSQsThlkjWuw_uLNng5aHNwa_GbupCx9IhN3Fvt-hO_P9gNIYIIv8EJ070NViKWm9XA6USs_W8ZKVRjqqTcwSz0l1GEOVy1Jzz5Sf_gabrfITLxwYTcu1uH1AIra6EFFzRRe1BvQS0afzlDjgllsW2287WPj5Ndo8cELITNx7dCeWK82h3qZ6tjrIoAPdtOGMYb0w7D9asiQ_V-UfpbL0PxYnZCuOTxyLbqztX2aQjnF-j_6GWydhlRWDuFSSl23NFz9xwQUCNzVL2cHZIBhzgq27liq--fZJJnUT6ZKd9AP-MDGYnkAt-T9TKV7djn_zSRb0-5vgBEwxMRve8nr4hZ7tw6RML3ZjkF0b365Zrna2RqHWLblT1n6jibJMTTF3EABIUFrqK0W0jzZGOuqq1ny7r39HiIBCt2ZxkBQezIeCjiRhl0KgdviLoMZf7MNguucPmrYjJQ1AtXC5w_Bzr5Kdqds7B5lyL1WL__waB2zNGxkhx_SC7oHENvYUQ1Psa-vEsJIHtmPmAIKRsQt5i97t2cNfgzfrB6RcVC75yS31YBi0a2GHvbSYrp7MT7Cwn94czHEx4e8L87QjUXSNOWDVSQ_j127vr9ddvKJmUS2LPeHKzXPKFvRel0mY21h7EX0Ls2rLad4oDdzM-hlmQvvge9OeT2gEB41zysuGxKxnCXupZYeSA3qHaPOmwzxdiOl2ny3hIEA2f7E83IzV0FOKxqO5MkMquHNboC2_DagEDv3BRwfI-G_nD5E8d8wcUUU94x2IOl4DgY7SPNPvWXFBWsmwm1TH-6X9qz6fwpemkq_zpXlJ9yuXUn_eneInGAWgjEcPgY4VRl-XAN97nYLa6xwUEZ5lTt2CLpT4SgTW6qd6V9jKkqcPCR497445QjjWGmk_kWzXeJgLDSfFWFSIIH7fDpqu7p_WGEst2W9pmuOafDjYP8wTWeUXV26gigo1LA_PEe_eSC1jui4pmQPMFmyEPOgr44q_oqK6g7JjuOPDdbv7fEg0-UQHjjM6QjPcMrOxLWi1JcLDz3maPMMMzKUZpqIxUTB1-ZoAySp5uvUqRU9T1X7gwyjtL007kcJzKCFgtf8mCqvapUsU5dQm8sjcd48vZF-LQ41D93tR_RL2sjdIXy1mzRfx0fN109BvKUbgb9yZD4vMpaWvsAWIKKcgbB2BQvCjj_4o-gzCqXwcLUMbmRXLIfqVcX168H0IMF8c8ekfOg6TYf1o3Pd_-FqGnIFxZlnBOarYBWqjjm7QlNzKSpS82e4dVTNRU-7WB3k65wEh-8bNPBIQjz6SlaLG7XYoePYofTY4-Ml2X0kl0SIhOYQ58cJhybmeO-48905vv2CZE9M56pLJK7hKSZx3KVzu6K5Hm-4RdnoOwYddZ7pjPIk18STCXOPQvqYZ70azZ1yTaI2YcAHCAAQyViM1X47VkKvo_191VHuwXlslYvE20CGqueLPnjdgES3_TxVXp2-BTWNvwLa7HGK5UY5mb6VBX39-EEsYkPuVJ5PzThwshkN8JGP0TYpd__DTSklDPUwF1NFTumYX7EqK-FItYc3NnTt01aAdAPn1lD-sz9F3qDP2RuXLw-gse4RJUGhKgTd8JRnKDdie10pbT9himyTBpuWYny0GCYWUfEgenHKMh6nGl3CrVdx7Ng7XZhTctQ78bJp8O9KnT1_42Na_nUqv89i9DtPw93vuWy1XCNGjSPIOm56K9xOzdjvviV8Nlvbdc40UbPeEp0QSuoATBAmbxWdiZZ5em0vDruLbJ9XrdHNrLUrGR4e3MZJw4bNXjYsuj7VH8-LlaxL5KgXumKIboENlCYZLpAHu3UcTuREb5Mnok6C5Il0_SLh14vrW9jRs8sNz5Koq75O855j0iy2Zw_3WOLU9QyDsrHzdRE3pbs9NGKQojq5EvxBkCpQvUy1A8Z15ZCxrVcD3t6Et_1A94Ah_JDE7xVv3FZhwrdwnXtty6SSU75pAnXA3a-AIRJtUs4FBJ6q8bRqb1uzdn-1BFjhJAhi1QqnuV7d8fetRbAk5XnQf6CtWHnqnOyWp4Y82un2wzfP0AqVHk3rJvJqEqgQ0iLlfMzNv8gYIMYcxQCptpXMkZpeNQkUkveJVPSe3MADNAuNuw-tH29faxzASkNSV5oyPB0Od2NzbZgKt2oK00YTtu3TsVNl7tGNvuoNSA4jGhwPnucwA0x5BJHvPAkL3IaPXmpzzFdo8Sx4-7-PVuJI9pByNMdT36m_TJf_v7JuLqRupHqiYxfMwO3OhCj1LCMSARIKO3f73jzJhDoUangFrhl1Zy0Rq5puD3smPZghiLRGJA9sLQsGrNn5a4cPoLmoxn54jhWhsURCHYjiJv71W552a1ZqlK1Mo2uKRxcoOKnL1Crcqkiq5DyXdK8bX3OGxJ0Tvn91DHRlN2AvpE3kWbHs02Eayj7U7SGg0nGmA7VEob3WrdGlfbpKs9-HiIAke4DKWdBXzgwp6459rKWs2Jck7ie6-dMQbTT2zoCO5DVe0EYi4AEUyau3g-LeS4SSApVuzdbiW7NhXPFIP1jkR2kGi4_TizmKSD-dZVn-jmtK41l3ZK5hHpX0Hbd9Zai1KLXHxru46HMgkhfNPMUHQu3d1KIVDj7AT4CIDUMU97xEMrhhMum2xI8MQVMndcUQQTnHhSFgArohwVS86DqerqS4_puXV6isXkNWW52dHZ40mXP8fpU9TKczE0Bsku28mIwFUTmvUARWzv8pes8Y5DmKCJmGmVSADOwiV8VNHAR3Ol_SzThyTns6zTmg45RVFvgeWtKKXNh1mXkgqgozVoqD6NLXDtjWEfcvpqIIE_soEwjDXHHgpLpleMA4GKnS1l9dBC6fIv7kEhFxpSEvKSbGznMBDBCa6_RjZw8ZX3A_iHnD2kr6nXLepzG3XiokyEXxi3ov0NG-8LpLvd7v5nVxJfmV4F9DprDHtTZWIY486Jm_V31X2Q3diLjFxebcKToSW0U78robOjXN3q5C5gAs_CcggmYddCNP0hLi1_BGZO0dCG_G_lLHe2sT8YxXJc7ONUBdasTuIQStg7LIHte-8aMCK4whQr-zoZgI2GUtNiaGuBaoEq8tiQO0DycuBYl39jQHLjyn813hAr34rZng_rkmBVIiLCqXMqAOOIsQW0VAIu4LeqZVApGraoVngAfvCnIVzl_bR1lahT-r4MkbFgpmxvvXqFw4QnXKO-Vsmm5TPOCi3-lip-EzZ4XQYMJUUiCl0WInu5dYJ1r_Qq40wdY_Y1eSTZdMUqIbSWIa13yfPnIEFa5sDMe_FRu7uuTz8NOZHFSQkMPZE2tULZ44HGcpkYRXeEtzR_mPPJuJlKUOFofEz0F9c1LZ3EduMDAA4rCVKXCKhCbVZYvFwExNRTneZK6kCeDSWXCj1wZEUNCLINZ6cQKTn5XQbZrjPkkuNj1xnmBTI2WetIX-EzHZd_AHQYbANTLExBmq2JJd7OpWqIP84PDC2bO4kHorYZbxs_96_AfdOgiHj_f3VmjmjlNkuaZIhDoEFEN-pRYWO_YCwBhF49D74IiF0hzCW4OCVBijBgMIQbptiOZJVitUe2s970bdvzCNsP4ij94YElLlTUdZCsx-Y9gqQH9K0b0-kfUm4oP7bjN4-1d1BA7rSO7n2N8yCfq2zF94hnIw_hdiQ_GKGMtzOcHzhrJrFjlBsYLZ_9gXqMSoQDP4wf-bPz1RdHVOi_aW7f6fvM40Z-0o714SxRYkU2gAoQlLj7H_oXxstUAldpIA2tiqtdvRxGFa4aN-qqvaGgiH_0HCp5zJ6KPktPZBhDBSbQzWqZuFvLNPfzO4BqYFOoPADVksq0WOvg4o0wVchFheqnkCczHQVGNkyuyQllcbkDCyJFpwA8RY-A8DgNzKW1ekG8681oh0ryPwZkYWgsz6StZn9csLesN_OSASUUabvGAt6FBcuHhn66_jVgvRH4G-diSvfoLcqtOUkWxL-BkAx1lLQSAlYY0RBZYKcSEViUh75UVK0XveRVyiqNTQYZcmc9ChMQyXBBUQvXJfLByI0orVfDBzE92yvKnDqLP886_xSDBOLELcBjhqUTklIDVDNc1ysrZNTTu5IcboM0V0ZL303Tsr46kuXfQEqwdWD2oxz35R2OzWcHHLHUNmVQjUrR6aYEF4ejZ3mM7Hj0F_kK04n8c2M6mNBjtHKjDzHCklHjtDUNJP3qXJrQv0gU4-6fMObEAcSZihT-o7bHuVB3YCSVdePnPz0En2Ef3NYEyWTwpeGDBzAQFTZASAO_ioubV3-AXNlFG9Kwb-047o0tFmFHGkgj9KPcRUqpF-EJKAb65AhrNeb-jCPXZfFcN7UI-Zn6ExJ7iL9K7Z-f_QaQ2ea0Ge5Ri2n_ikGZ4Iu7HbCI4-Lsilflm0v0qVDlPpHCxJ_LwTO-w_Y06sC8oXhD5HWAQwUoQYj4dE7kwzGGujT2oNXJ7A-_1f1l-Uc5tuD8EWlvynlyTtDPU9HTqEQiQKjEIR5ICrV9P2Fr7Ju9dJytcTTE8XcAKv03kZ14JK8uajIumsB6KSOpcvEgDE35FZ5iNpfWpGzbUz7p-SsKV6CQtUK5c2TcbXgvU--I7UrCPYirYDk-Jyj9TOAaydl6ZbpSrbAWbzpWKMzjhYOkRknljikv-avCepQJ86X7T0XUubULodq9AfjXPLoGw5pvHse-FQZtj6dGf58KI8h3rnZ65kfYQ2LhPpXAxdVcdGYGjnvmB8ovVnuE-F-ZR3EJHiKJV8Tb9SNKgGL3k6kRoKUj5blfxrsYiyySfFT1N88zsrjKx9rDN25Y_WuCOhX7C9O5Zm0r1njiZQBYUxj3B-sdSnisKVGngWm37PmSm3bfJ26wf2v-TZH-n2AH-lSXeA2UAJBnh0g507JLTYnbiylLoRnEuQToWJNf9DI50wJfXmHv4iKWNLWXIzem00RtUJlD-hhc9koAcIGAHCna3pZbKiyNqE43f0_mLwP1ENes_rriUR8DUeCDXVOIE39X9sRrnRmjapaTWYHee0f2ttc8fhGuV0rp4JRsL8FQBLVt6SG0c9aS_Iqp561poOGDp23WBF5AV8MoeCQ-DxXFyvOLo2X1K8pQyMZnP9LHYESMluxBE9tKEDLkENFSex6xR4ltd3DB295zxDKTnqsBB30RkDQGRhf9554LLMthQqGWPzx-X4al5vPoaDI49VbBNGrrBNcVi0yXGUSFvkmutOpZgOGQYXXILrG4yyRXslRXc3ynjAf5j3zcRruILQmfg4PypdSVMktdWC_KG8LyXtQjGCsYBvIm_MpXBcLIOf5mqPe9nhESbvaamL1dnzHp8HXOai9THZ4_mopqeSeNb-aZDD2OOjoHlU8=",
                "id": "rs_04b8c8013179d20601690915e076408193a0d6108e27587fb4",
                "format": "openai-responses-v1",
                "index": 0
              }
            ]
          },
          "native_finish_reason": "completed"
        }
      ],
      "created": 1762203103,
      "model": "openai/gpt-5-mini",
      "object": "chat.completion",
      "service_tier": null,
      "system_fingerprint": null,
      "usage": {
        "completion_tokens": 950,
        "prompt_tokens": 333,
        "total_tokens": 1283,
        "completion_tokens_details": {
          "accepted_prediction_tokens": null,
          "audio_tokens": null,
          "reasoning_tokens": 832,
          "rejected_prediction_tokens": null,
          "image_tokens": 0
        },
        "prompt_tokens_details": {
          "audio_tokens": 0,
          "cached_tokens": 0
        },
        "cost": 0.00198325,
        "is_byok": false,
        "cost_details": {
          "upstream_inference_cost": null,
          "upstream_inference_prompt_cost": 8.325e-05,
          "upstream_inference_completions_cost": 0.0019
        }
      },
      "provider": "OpenAI"
    }
  },
  {
    "request": {
      "base_url": "https://openrouter.ai/api/v1",
      "model": "openai/gpt-5-mini",
      "messages": [
        {
          "role": "user",
          "content": "A 65-year-old man presents with progressive, short-distance, intermittent claudication in his right leg and a declining ABI. He undergoes an abdominal aortic angiogram with runoff demonstrating a discrete 90% stenotic lesion of the superficial femoral artery. Percutaneous transluminal angioplasty followed by placement of a self-expanding nitinol mesh stent is performed with good post-procedural angiographic results.\n\nWhich of the following is the most appropriate post-procedure surveillance program for this patient?\n\n A. \n B.\t\n C. \n D.\t\n E. \n\nAnswer Choices:\nA. Regular visits with assessment for interval change in symptoms, vascular examination, and ABI measurement beginning in the immediate postprocedure period and at intervals for at least 2 years\nB.  Regular visits with assessment for interval change in symptoms, vascular examination, and arterial duplex at 1 month, 3 months, and at month 12\nC. Regular visits with assessment for interval change in symptoms, vascular examination, and ABI measurement at 3 months, 6 months, 9 months, and at month 12\t\nD.  Regular visits with assessment for interval change in symptoms, vascular examination, and arterial duplex at 3 months, 6 months, 12 months, and 2 years\nE. Annual visits with assessment for interval change in symptoms, vascular examination, ABI measurement, and arterial duplex"
        }
      ],
      "reasoning_effort": "medium",
      "response_format": {
        "type": "json_schema",
        "json_schema": {
          "name": "answer",
          "strict": true,
          "schema": {
            "type": "object",
            "properties": {
              "answer": {
                "type": "string"
              },
              "answer_letter": {
                "type": "string",
                "enum": [
                  "A",
                  "B",
                  "C",
                  "D",
                  "E"
                ]
              }
            },
            "required": [
              "answer",
              "answer_letter"
            ],
            "additionalProperties": false
          }
        }
      },
      "usage": {
        "include": true
      }
    },
    "response": {
      "id": "gen-1762203103-rQEyzBr8x4ZjGX6fMdw2",
      "choices": [
        {
          "finish_reason": "stop",
          "index": 0,
          "logprobs": null,
          "message": {
            "content": "{\"answer\":\"D\\n\\nRationale: After femoropopliteal stenting, surveillance should include interval-symptom checks, vascular exam and routine arterial duplex studies (not just ABIs) to detect restenosis early. Duplex surveillance at about 3, 6, 12 months and at 2 years is the commonly recommended schedule to monitor SFA stent patency and allow timely reintervention.\",\"answer_letter\":\"D\"}",
            "refusal": null,
            "role": "assistant",
            "annotations": null,
            "audio": null,
            "function_call": null,
            "tool_calls": null,
            "reasoning": "**Selecting surveillance program**\n\nI need to select the best post-procedure surveillance program after an SFA stent following angioplasty. Guidelines suggest using clinical follow-up, ABI measurements, and duplex ultrasounds at specific intervals to check stent patency. For infrainguinal stents, the recommended schedule includes a baseline ABI and duplex, followed by routine duplex ultrasounds at 1, 3, 6 months, and then annually up to 2 years. I\u2019m realizing that regular visits alone might not capture issues like restenosis effectively if ABI readings are normal due to collaterals.**Evaluating surveillance options**\n\nI'm looking at different surveillance options for post-procedure care after an SFA stent. Option B suggests arterial duplex at 1, 3, and 12 months but misses the 6-month check. Option D, however, includes checks at 3, 6, 12 months, and 2 years, but it omits the 1-month check. Meanwhile, Option E proposes annual visits with ABI and duplex, and Option C focuses on ABI checks at 3, 6, 9, and 12 months. The recommended guidance highlights the crucial need for duplex ultrasounds at 1, 6, and then every 6 months for 2 years.**Determining appropriate surveillance**\n\nI\u2019m checking typical practices for post-stent surveillance. Many centers do duplex ultrasounds at 1 month and 6 months, then annually, but my options don\u2019t match those guidelines. According to the Society for Vascular Surgery, surveillance for infrainguinal bare-metal stents includes a duplex ultrasound at 1 month, then every 3 months for the first year. The patient with an SFA stent needs arterial duplex assessments at 3, 6, 12, and 24 months, which lines up with Option D. Other options, like A and C, seem insufficient.**Explaining surveillance preferences**\n\nDuplex ultrasound is the preferred method for monitoring SFA stents because ABI readings can sometimes appear falsely normal. I need to recommend an early post-procedural duplex at 3 months to check stent patency, along with regular assessments at 6, 12, and 24 months to catch any restenosis. I also need to consider symptom checks. So, my final response will confirm answer D and include this reasoning. I'll format it as required in JSON with the answer string and letter.",
            "reasoning_details": [
              {
                "type": "reasoning.summary",
                "summary": "**Selecting surveillance program**\n\nI need to select the best post-procedure surveillance program after an SFA stent following angioplasty. Guidelines suggest using clinical follow-up, ABI measurements, and duplex ultrasounds at specific intervals to check stent patency. For infrainguinal stents, the recommended schedule includes a baseline ABI and duplex, followed by routine duplex ultrasounds at 1, 3, 6 months, and then annually up to 2 years. I\u2019m realizing that regular visits alone might not capture issues like restenosis effectively if ABI readings are normal due to collaterals.**Evaluating surveillance options**\n\nI'm looking at different surveillance options for post-procedure care after an SFA stent. Option B suggests arterial duplex at 1, 3, and 12 months but misses the 6-month check. Option D, however, includes checks at 3, 6, 12 months, and 2 years, but it omits the 1-month check. Meanwhile, Option E proposes annual visits with ABI and duplex, and Option C focuses on ABI checks at 3, 6, 9, and 12 months. The recommended guidance highlights the crucial need for duplex ultrasounds at 1, 6, and then every 6 months for 2 years.**Determining appropriate surveillance**\n\nI\u2019m checking typical practices for post-stent surveillance. Many centers do duplex ultrasounds at 1 month and 6 months, then annually, but my options don\u2019t match those guidelines. According to the Society for Vascular Surgery, surveillance for infrainguinal bare-metal stents includes a duplex ultrasound at 1 month, then every 3 months for the first year. The patient with an SFA stent needs arterial duplex assessments at 3, 6, 12, and 24 months, which lines up with Option D. Other options, like A and C, seem insufficient.**Explaining surveillance preferences**\n\nDuplex ultrasound is the preferred method for monitoring SFA stents because ABI readings can sometimes appear falsely normal. I need to recommend an early post-procedural duplex at 3 months to check stent patency, along with regular assessments at 6, 12, and 24 months to catch any restenosis. I also need to consider symptom checks. So, my final response will confirm answer D and include this reasoning. I'll format it as required in JSON with the answer string and letter.",
                "format": "openai-responses-v1",
                "index": 0
              },
              {
                "type": "reasoning.encrypted",
                "data": "gAAAAABpCRXvaC3BqKIizJmfwhxddUQfxRvVGebqDHGH3ftostJHpsfQfnncFVHsEeSJmwHDwkfMbKCcgVKU_npEWnIObe-LTFzf16cDL4lqzrEbLOPJ8ihbHFA8J1kKELsWcF5NJaysFVXq6waK_f2SY7MvXcWDcVFTy7GKCOgGXeaYwKTkN_337e2ieYGXwz3qC_ey2AgfrO_7tQOy_ij8b8kucRDzoxg-LhJon1aoRahBmGcyvaXIk-9CAa1zabxchqRSbndrixBY3mJZbfswodGACj_YQy1CgxzQbicCXpNwYnDiqUsxGfe29v7m5yMuJEi0Yrlv0mtEmOkMoyiGfIYikuldVWVdW_UTYvB1w6wnkLtbNPnyX9vMddiKpR_2he9YDC3EGYWE749NEil9PohohmD1g30WYKMS7KX2bqy97rwzdnUnkwsm-IgeitouwOgBo76PNQPom8h8pY08f8tcGu_STErrVHtWKQSZQuKAWxm-r6M1kY63hQXRueV5vhI82FDEuZNfvhLVGohOGkbRQ8j1FSWU_qXdpSNVRSxQ6L28HqobXeZoMc4omLV8K7iV089KNsBMx9ygQg_nXFtdN5aTYVZC3-O0w4UQdRPZccwFGhuLc83N2D25NYiElzOLpsFuUlQgv7I28hv7FFNARzIpCImsaeZRBYwYcXUOzzl3z2dkZ869iwqmWkFleoUvdwEvIcACJmvHdrbaMZDid4Td5IAZKn-yjPbUEfXzHGHU39iC_9HaYNzEEzkbmiF9tJ-ivY5wGyGXdtRtERh92HIHSOPEtdqQpFVM0HB05RvXXpdUAp1QR5zB866R2jDHiJRg2xiW6aWMU6lAD7tjy-_3BxFLKi_9LmdJD6tO7qIxvZ5nJXysQp6dH7GFDFkRpFXqXd37OGlduQ0afKGmoIJ0SbGHQmPTLDYnFtZzN1ZGEOaoc0j50PmQOYrr_pNiFwyB2jzhpBv-35hs0nFX18m2oDsBkMCLOX9XEIQ5Ngz7xlYbVu_cIG8i7iiwg9b99upApxqH63SevmAaP_r-KCqrS8CvcsDickEsoM-04-hQW2NLD5eToFo-Lpa4w1b6FqPZZti--XytUUEwLlvNm4o65DQc3H2zqcbw1t2KPbNmFDk2sf8kj7Goo72mDEBV1vsnvCSPtvvaTtLzSMeH97i0hDAZ6v2BSRKg_50BpkiKGWG7--CTu9eczDW1LNfdhKZRmc8dmMlwUDHcGx1hWOeFE5okDuDb7Goqu_JP_yMIeRJkzExZo9H-MgJrMAwOjLzUPoQVWCqnq8ImHqwaD2AVH0SDDUYjSFSIHeffFskjccCKnvPD3xoBgG2TBAt0VOYl5GWq4g4p-4cSbc0vN3I0IRYBiihwJRVQG5JpgfODYZJrPyVgNz4VGZ90KXrclcQnj4XPcWDexl-T6E5WCs8RblzIqTCCT4vxBaM6bFXUsvt0-Tpo97VSYwHqZ-qrsuW_pfx4l6hZwCgKqNikJfxGomfzYFCfpy9Q5QSuyyQpL9X7Xb06fIiuxg7zj5B0n2CFUx2Bo0xHDRB7YRuoE8w2ESJOPYBrxy43dIn6limIE4jLTqsNFoPmQU1rsw9Qk-JnCCUbNwb1svmkzuxMoh4XuCbmUfDWSOUL3oXnzR6gyGXYYJUJWDjyVLjG1pP3V0CsmY3PxP-YvG_ltvghrPInjbkok1yUqDr8yahwUvVK5QOmud2Gyk7CYwi2vvEY2HAB5kZGmlN-kco7nxWZ4b_zC7wvrqPUWrzOywonPUmYHtlhDXcbRDXD1HFF8uKVaqnuF7i_8cyOW6lAVNKjwyB5vtSFnS0t_KApIp9YKz9r0Oqica2kd9gKOpwGkKWQWf4WVbc-bBtZYPv4KwA8Z_Bz_UDT-erVH1_cXCeYJ5syZdc8uTTX7agGPBH0jj3XhWqQRpznIqVBZzQ2jNlgw805cfKqaZrz9g8TBjWSmPEnlMcDyWQI6r2k8Y6fO7Ko0cNp5BWgCVhJkgzX_qs5S5pU5jDryAMGAjdGD6CCUPEMAIfFeg90xQ2iyhkNbDXw6-5cdxblQjd1UD-NpLTOXI7rX-FX1YPJVWCC_9RnCvWiXKDOKheewjkE7ZoYi7ki-fS5E4a7l1BSOXDXyDggyoQDXhlSTOShRgncI1pSDodrl9u4ost8B0ySluAfj2y5UL7e0MKHUSLLHuprF2LQrQe7ainjW2HMXsBJ2XzTXAAFzQNidz-rtcVolzL6o6HB87_OhWD-UsBELoyvKLG5K2KvI1n4rXvTPu8OB83tNrFQ2AD_8Aw3-MCjcmN5qnDJTASdWi80429Xn-4Zyzt2JY_KVzBwxna7alXmXkL-Ox9Ybya03N4PGrY-pemPqRkx2gd3G2EtnXE0mnOoLnsA-GXSnzAOSZcvqEOLQ3UmkpjH0Wo_j_GlnQc8mL1C-P-ylvhXQKUurv7oCYYQh2Qo39b8UFkUYXycmCZ1JrrWIzXm1WflxW1sLN1TWOr4Gq6y9l_VLaLBPKGZ_tp3pwpBpEftk2fsVGu8h35h2y_qcJ2u8hLGVP592cpOfgc0A5pd_T5N0KBw3nbzu0axF3xGz332UYoLaxbXKpjTYAU9yDVE4EZ03SB-NLgtdGmL9YB2GwVUBKInEumBkqp6ZV2DBItP-UNs0a19lg9Gki9q1igMSs3Qd_pJiQa06oYMpupqkuOFVHXdAER8qoy721t6Ll31ealqw4qpsLnN9uHimssUKRDjAvsSuYRiFZ0Af6mTGeyc71x8A3Muw6RtJKbEvJeywAEjBg2XG68DnOFD3fD8U7yo-hHuPBkWIpwQe90JTwAujpDIfzgmNHoM5wsftx9jbY5IRRKH74c7l4AQH2WZbE6u4IZTUenky34UqnQKlvnyptFLSkIDpmMswbasuEidn46W9Vldw4YL2msQP8CLnNHUCqy8qMpdeuvh54sd6PeEInRfeFi3T1vXQdsxahsvzZ6_NXKIgjB-YMAb8NjzzqpUlSNfVfM7z3ADc582s1KJjU1J646ZYjjo-EAUOefHZ8MPDb56H-QWU582vZPguT8o8cHCf8GFq-TKDC9THDR2gQEh0qr_ME7_MuhsHjsFjYB18IIYhMPTJIPj1MI9uMT1SUzGt3ErgeXsLCR29C6uQRRqvjRHiO4CFYtstt1DEp2tDczIAy3rM0pNLt3qc4uOY60loqmQGysqV8Q-XcX2337EZ3gnifMRMAb_yVnVgXU_P2NG0ucIlQrWoaYFA_4CZ3c3mY3vfrHeu837Q0oI0Cz24WbgawGzw6v96WCy7QSM2AtqIu2MKr43XTmp_60t4_Ol-CMfhPjFyla6MAc4gcmy2xSUj96tt1_W7QUnBhVRtjXiyFrYWL4YoAekkfvwr7IpGYuViPr9ASmiVmlVvx57xb0PzlsLMCwhiCFsboxSzt5iKADAChI9ryP3yN3RJGOFAMJZMVyJPjSNqWPwtHNn67_Eobb9Cln1zj2Aad__-Kx0OEcE0w_9_Gekoe_pgBVnBOMO_UjhF0f4aOXiskIaoxd8Fwtzp3zIkqlmKRMyGatcyyFsvjEt8z14QPZagxJXTXoHv9qyO1gD2Dqlnj8QNFN7J6wTtyZHqiR3HJAGOv_wnu71qrxwe0uQayJDxr5EU-VcysDi3y88FAnUy-4KfLfzxvRfgdrfQziQAwDsO2NjUq_VW1d_nxVC8PiNHmX5NeCMbR6r3NGHtWiBfhsbANpy4dd_1-4fsbyoH7MWk-JjZMs1MM9wPjNeZumkrMKOGQnm3142-pf8NktL5ntFpitPF4hB8J0ONj_Rq1FENaS-4d3Hb_WwB-brLfsNViXG-AZKKZ070uVO51hdKPE-1bF8mkiXdmyvNkN3rzrnpk1chV6M3ry6byERlsnka1_5895Yrz1e8jLa_k6VNK8-NwpzHwdWzGjuGFwKtEfwUJzdD_0DFcLYQAp5G9qiNcSR4FNGzLEOhzVRgYfyJ-Y1J5s4r2mZITvBsp9aHEHz2WT-arRxZ6YGXkoUmg8HyJWYRsShnFWy0QRJUfUMB3mjW6mQ9ROG1DQ9Lw99T-kkIG_XSVAuDgkCTBjyopTgijCjLjN6IC1wfz0CBzAuoDsE5wZq-pej44uNyxkYbTEXyJeShXR4BfyTZTXFERjXewl295yJwOyPg9E6xnVegR3rDnLrDfeIc6CH7gZzNczx6hh4imkQSE85EFqNBq2MG6z4LLpuTgF7O5p4-nkpswLXsfjXEsY6yqCyqyudfr6aAisF4rSAnZ5HJnBL1CJDgxXpPRMzjHrMvmysq63LY2mZwGHDb7XBMKV_IBeIj-bAEODLkhlBn_gbzZFjXKLMPPd4dXY8WYgmao0MwZRWuUHTQWeuuYEgRVWJdE9CAavcU-x6DaapG64qc_9IDlKC_9rLqGprjlzargr1TnGDLY55-J-BOJefmYmWrtjnugJ2QDhC8d6Tedeft36PX3taXMozXWN58IhIXGoIICjd7SokH5uA0RAUGuL_pHcQdV5F0eE1g4QQ8fiLEcpnQ4-sCsijpSaelMH7qICBouLwpEH1tF8SiqJ27GVMWq-zW6uqFhdksd8SFlOhRpQVApxeSKbGu3f36deSkZANqCo0RUVcPi56z17-7wugvMajOes3KUkKYFSQvv6OUQMU_VenEnMhysnLmEN1yEXkrIoCnudZY1BHKjtMmNGwzpnUJYR7Y2IaIX8eImRigHvkg6JeAWVAlp1T6QU7z6G6nEqSEWo81qVq-U_Y2GxbJPVhqMGQpSU0YmYNpRUezRjcVsnhd8K-ZEuYX13ZSri-h97EjgZO4GO1GLApB0RzeqAKmtl7r3lrYfQlveFWnB5G_-D9UTvMJZlTm7GbuBA0B8c6ggDLtiFI8Y-gpPF61783Nx-zCgWZntA_A6QnZBXUrGHF_3XMg9vALwDD-t6LuQjM9VEwZ5Ay_CPAJb2GBwO9Ao91nQT3Gwln6kUKgv_qhLg=",
                "id": "rs_027f51e1908a8a6f01690915e04980819498559de8e57fdf5f",
                "format": "openai-responses-v1",
                "index": 0
              }
            ]
          },
          "native_finish_reason": "completed"
        }
      ],
      "created": 1762203103,
      "model": "openai/gpt-5-mini",
      "object": "chat.completion",
      "service_tier": null,
      "system_fingerprint": null,
      "usage": {
        "completion_tokens": 803,
        "prompt_tokens": 333,
        "total_tokens": 1136,
        "completion_tokens_details": {
          "accepted_prediction_tokens": null,
          "audio_tokens": null,
          "reasoning_tokens": 704,
          "rejected_prediction_tokens": null,
          "image_tokens": 0
        },
        "prompt_tokens_details": {
          "audio_tokens": 0,
          "cached_tokens": 0
        },
        "cost": 0.00168925,
        "is_byok": false,
        "cost_details": {
          "upstream_inference_cost": null,
          "upstream_inference_prompt_cost": 8.325e-05,
          "upstream_inference_completions_cost": 0.001606
        }
      },
      "provider": "OpenAI"
    }
  }
]